Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707) — Financial Flexibility Index
Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707) has a Financial Flexibility Index of 0.15x as of September 2025. Free cash flow of CN¥520.36 Million (operating CF CN¥502.01 Million minus capex CN¥18.35 Million) represents 0% of total liabilities (CN¥3.56 Billion). Check Nanjing King-friend Biochemical Pharmace strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Nanjing King-friend Biochemical Pharmaceutical Co Ltd Financial Flexibility Index (2013–2025)
Historical Financial Flexibility Index trend for Nanjing King-friend Biochemical Pharmaceutical Co Ltd across 13 annual periods. See 603707 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Nanjing King-friend Biochemical Pharmaceutical Co Ltd (2013–2025)
Year-by-year free cash flow to debt coverage for Nanjing King-friend Biochemical Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Nanjing King-friend Biochemical Pharmace market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.51x | CN¥1.74 Billion | CN¥1.18 Billion | CN¥3.44 Billion | ▼ -23.8% |
| 2024 | 0.66x | CN¥2.01 Billion | CN¥1.50 Billion | CN¥3.02 Billion | ▲ +21.5% |
| 2023 | 0.55x | CN¥2.04 Billion | CN¥1.62 Billion | CN¥3.73 Billion | ▲ +97.3% |
| 2022 | 0.28x | CN¥1.07 Billion | CN¥595.45 Million | CN¥3.84 Billion | ▼ -30.6% |
| 2021 | 0.40x | CN¥1.12 Billion | CN¥683.63 Million | CN¥2.81 Billion | ▲ +685.1% |
| 2020 | -0.07x | CN¥-271.49 Million | CN¥-565.85 Million | CN¥3.98 Billion | ▲ +80.5% |
| 2019 | -0.35x | CN¥-725.98 Million | CN¥-841.38 Million | CN¥2.07 Billion | ▼ -336.6% |
| 2018 | 0.15x | CN¥145.13 Million | CN¥62.37 Million | CN¥981.21 Million | ▲ +161.9% |
| 2017 | -0.24x | CN¥-153.45 Million | CN¥-234.59 Million | CN¥642.50 Million | ▲ +76.8% |
| 2016 | -1.03x | CN¥-214.28 Million | CN¥-286.79 Million | CN¥208.09 Million | ▼ -230.0% |
| 2015 | 0.79x | CN¥162.15 Million | CN¥137.28 Million | CN¥204.72 Million | ▲ +93.4% |
| 2014 | 0.41x | CN¥208.14 Million | CN¥178.74 Million | CN¥508.26 Million | ▼ -77.8% |
| 2013 | 1.84x | CN¥255.87 Million | CN¥193.91 Million | CN¥138.91 Million | — |